ADC lsotype Control Human IgG1 (MMAE)

Cat. No. / Size
Price
Availability
Qty
DNP-B904P1-100ug
$195.00
In Stock - Delivery in 1-2 business days
DNP-B904P1-1mg (500ug X 2)
$790.00
In Stock - Delivery in 1-2 business days
DNP-B904P1
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Source

ADC lsotype Control Human IgG1 (MMAE) (DNP-B904P1) is a chimeric monoclonal antibody recombinantly expressed in HEK293 cells, which combines the variable regions of a mouse monoclonal antibody with Human IgG1 constant domains.

Antibody Type

Recombinant Monoclonal

Clone

AM2

Isotype

Human IgG1, Kappa

Host Species

Mouse

DAR

4

Purification

Protein A purified.

Aggregation

Less than 10%, as determined by SEC-MALS.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

Background

MMAE (Monomethyl auristatin E) is a synthetic microtubule inhibitor. It binds to tubulin to prevent microtubule polymerization, inducing tumor cell cycle arrest and apoptosis. As a highly toxic payload commonly used in ADCs, it has excellent plasma stability; when conjugated to antibodies, it can precisely kill target cells and is widely applied in the R&D of ADC drugs for hematological malignancies and solid tumors.